BQ Blue's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer BloombergQuint's subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
Max Life Insurance continued to demonstrate a resilient performance in a challenging macro environment, led by healthy 32% annual premium equivalent growth.
This was owing to robust growth in non-participating savings and recovery in unit linked investment plan.
However, protection growth has moderated, similar to that for peers.
On the distribution front, the strong push via the bancassurance channel has aided premium growth, while proprietary channel growth was impacted by Covid 2.0.
Max Life's value of new business margin declined to ~19.7% in Q1 FY22 (versus 24% in Q4 FY21), largely affected by seasonality due to the drag from operating cost and rising ULIP mix.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
